Bombesin is a potent releaser of many gut and pancreatic hormones incl
uding gastrin, glucose-dependent insulinotropic polypeptide (GIP), pan
creatic polypeptide (PP), cholecystokinin (CCK), enteroglucagon, and i
nsulin. Three mammalian bombesin-like peptides, gastrin-releasing pept
ide (GRP), neuromedin C (NMC or GRP-10), and neuromedin B (NMB), and t
wo bombesin receptor subtypes, GRP preferring and NMB preferring, have
been characterized. We used a highly potent, selective antagonist of
the GRP-preferring receptor, [D-Phe(6)]bombesin(6-13)-methylester ([D-
Phe(6)]Bn(6-13)OMe), to determine the receptor subtype mediating bombe
sin-induced secretion of gastrin, GIP, PP, peptide YY (PYY), and insul
in, as well as the importance of endogenous bombesin-like peptides in
controlling basal secretion of these hormones. Unanesthetized rats rec
eived femoral vein infusion of saline, bombesin (10 nmol/kg/h), [D-Phe
(6)]Bn(6-13)OMe (1000 nmol/kg/h), or bombesin plus [D-Phe(6)]Bn(6-13)O
Me. Blood was withdrawn from jugular Vein catheters before and 30 min
after the start of infusions. Plasma gastrin, GIP, PP, PW, and insulin
were measured by specific radioimmunoassays. [D-Phe(6)]Bn(6-13)OMe al
one reduced basal insulin levels by 28% (p < 0.05) but did not alter b
asal levels of plasma PP, GIP, PW, or gastrin (p > 0.05 for each). Bom
besin infusion significantly increased plasma levels of each hormone (
p < 0.0001 for each). [o-Phe(6)]Bn(6-13)OMe completely blocked bombesi
n-induced increases in PP, insulin, and gastrin, and almost completely
blocked increases in GIP and PYY (p < 0.01 for each). Our results sug
gest that (a) exogenous bombesin significantly stimulates PP, insulin,
GIP, PYY, and gastrin secretion, (b) bombesin-induced secretion of th
ese hormones is primarily mediated by the GRP-preferring receptor, and
(c) an endogenous bombesin-like peptide acting at this receptor subty
pe plays an important physiological role in control of basal secretion
of insulin but not PP, GIP, PYY, or gastrin.